InnovAge Names Darlene Flaig as New Chief Nursing Officer

Published on October 2, 2023

DENVER, Oct. 02, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), names Darlene Flaig its Chief Nursing Officer

Continue reading on website
Other news

Antibody-drug conjugates and the link to fighting cancer

September 29, 2023
Since the approval of the first antibody-drug conjugate (ADC) in 2000, ADCs have become a massive  focus in the oncology sector. This is due to the fact that they are able to combine highly specific targeting with a potent cytotoxic payload to deliver exceptional results.But how have they been so successful where small molecules haven’t? Abzena’s Chief Scientific Officer, Dr Campbell Bunce,  share

Antibody-drug conjugates payloads: then, now and next

October 4, 2023
Antibody-drug conjugates (ADCs) have been a revolutionary new approach for cancer treatments, with their ability to deliver cytotoxic drugs directly to diseased cells while leaving healthy tissues unharmed. This direct delivery reduces the harmful side effects commonly associated with traditional chemotherapy while allowing enhanced therapeutic efficacy.In a recent article with Drug Target Review,